Toronto - Delayed Quote CAD

Medical Facilities Corporation (DR.TO)

15.54
+0.17
+(1.11%)
At close: May 16 at 4:00:01 PM EDT
Loading Chart for DR.TO
  • Previous Close 15.37
  • Open 15.28
  • Bid 15.57 x --
  • Ask 15.63 x --
  • Day's Range 15.28 - 15.79
  • 52 Week Range 11.40 - 17.97
  • Volume 21,370
  • Avg. Volume 85,927
  • Market Cap (intraday) 302.514M
  • Beta (5Y Monthly) 0.66
  • PE Ratio (TTM) 7.23
  • EPS (TTM) 2.15
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield 0.36 (2.32%)
  • Ex-Dividend Date Jun 30, 2025
  • 1y Target Est 16.24

Medical Facilities Corporation, through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States. Its specialty surgical hospitals offer non-emergency surgical, imaging, diagnostic, and pain management procedures, as well as other ancillary services, such as urgent care and occupational health; and ambulatory surgery center provides scheduled outpatient surgical procedures. The company was incorporated in 2004 and is headquartered in Toronto, Canada.

www.medicalfacilitiescorp.ca

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DR.TO

View More

Performance Overview: DR.TO

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

DR.TO
2.14%
S&P/TSX Composite index (^GSPTSE)
5.49%

1-Year Return

DR.TO
33.70%
S&P/TSX Composite index (^GSPTSE)
16.47%

3-Year Return

DR.TO
108.73%
S&P/TSX Composite index (^GSPTSE)
28.53%

5-Year Return

DR.TO
408.82%
S&P/TSX Composite index (^GSPTSE)
77.42%

Compare To: DR.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DR.TO

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    302.51M

  • Enterprise Value

    310.03M

  • Trailing P/E

    7.22

  • Forward P/E

    10.17

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.79

  • Price/Book (mrq)

    2.69

  • Enterprise Value/Revenue

    0.67

  • Enterprise Value/EBITDA

    2.69

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    22.78%

  • Return on Assets (ttm)

    10.15%

  • Return on Equity (ttm)

    57.20%

  • Revenue (ttm)

    331.27M

  • Net Income Avi to Common (ttm)

    30.39M

  • Diluted EPS (ttm)

    2.15

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    65.72M

  • Total Debt/Equity (mrq)

    67.90%

  • Levered Free Cash Flow (ttm)

    56.87M

Research Analysis: DR.TO

View More

Company Insights: DR.TO

Research Reports: DR.TO

View More

People Also Watch